|
⚲
|
| Keyboard |
| Crestline SI GP LP
✚
|
|
|---|---|
| CIK # | 0001626597 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001626597] | |
| 4 | [0001626597] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Denali Therapeutics Inc DNLI
Common Stock
|
2021-02-12 | Sell | 2,216,798 | $65.00 | 144,091,870 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-08-12 | Sell | 1,443,247 | $31.65 | 45,678,768 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-06-05 | Sell | 1,922,855 | $25.75 | 49,513,516 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-02-26 | Sell | 3,894,764 | $20.25 | 78,868,971 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2017-12-12 | Conversion | 128,200 | ||
|
Denali Therapeutics Inc DNLI
Common Stock
|
2017-12-12 | Conversion | 743,599 | ||
|
Denali Therapeutics Inc DNLI
Common Stock
|
2017-12-12 | Conversion | 1,875,000 | ||
|
Denali Therapeutics Inc DNLI
Common Stock
|
2017-12-12 | Conversion | 14,499,999 | ||
|
Denali Therapeutics Inc DNLI
Common Stock
|
2017-12-12 | Conversion | 2,500,000 | ||
|
Denali Therapeutics Inc DNLI
Series A-1 Convertible Preferred Stock · derivative
|
2017-12-12 | Conversion | 14,499,999 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Series A-1 Convertible Preferred Stock · derivative
|
2017-12-12 | Conversion | 743,599 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Series B-1 Convertible Preferred Stock · derivative
|
2017-12-12 | Conversion | 1,875,000 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Series A-2 Convertible Preferred Stock · derivative
|
2017-12-12 | Conversion | 2,500,000 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Series B-1 Convertible Preferred Stock · derivative
|
2017-12-12 | Conversion | 240,000 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Series A-2 Convertible Preferred Stock · derivative
|
2017-12-12 | Conversion | 128,200 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2017-12-12 | Conversion | 240,000 | ||
|
Denali Therapeutics Inc DNLI
Common Stock
|
2017-12-12 | Buy | 275,000 | $18.00 | 4,950,000 |
|
Juno Therapeutics Inc JUNO
Common Stock
|
2017-07-13 | Sell | 8,000,000 | $27.00 | 216,000,000 |
|
Juno Therapeutics Inc JUNO
Common Stock
|
2016-03-01 | Sell | 8,600,000 | $39.00 | 335,400,000 |
|
Juno Therapeutics Inc JUNO
Series A-2 Preferred Stock · derivative
|
2014-12-23 | Conversion | 8,750,000 | ||
| showing 20 of 30 most recent transactions | |||||